US Patent 9493813 Modulation of phosphatidylinositol-5-phosphate-4-kinase activity
Patent 9493813 was granted and assigned to Beth Israel Deaconess Medical Center on November, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+331 characters)
Article
Patent abstract
The invention features methods for identifying compounds that modulate the activity of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K). Inhibitors of PI5P4K can be used in, for example, the treatment or prevention of cell proliferation disorders (e.g., the prevention of tumor cell growth in p53 mutated cancers).
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09493813 Modulation of phosphatidylinositol-5-phosphate-4-kinase activity US Patent 9493813 Modulation of phosphatidylinositol-5-phosphate-4-kinase activity
Infobox
Patent Number
0949381300
Patent Number
949381300
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
094938130
Date of Patent
November 15, 2016
0Patent Application Number
139854620
Date Filed
January 13, 2012
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
094938130
Date of Patent
November 15, 2016
0Patent Application Number
139854620
Date Filed
January 13, 2012
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09493813 Modulation of phosphatidylinositol-5-phosphate-4-kinase activity
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09493813
Date of patent
November 15, 2016
Patent application number
13985462
Date Filed
January 13, 2012
Patent primary examiner
Find more entities like US Patent 9493813 Modulation of phosphatidylinositol-5-phosphate-4-kinase activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
